-+ 0.00%
-+ 0.00%
-+ 0.00%

SERINA THERAPEUTICS INC - SUBMITS COMPLETE RESPONSE TO FDA CLINICAL HOLD LETTER FOR SER-252 PROGRAM- SEC FILING

Reuters·12/10/2025 21:19:06

Please log in to view news